AZD6423 SAD/MAD Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteers.
Interventions
DRUG

AZD6423

Drug: AZD6423 Single or Multiple doses via infusion.

DRUG

Placebo

Placebo to match AZD6423 Single or Multiple doses of matching placebo delivered via infusion

Trial Locations (1)

Unknown

Research Site, Glendale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY